Article
US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics
Rating:
0.0
Views:
68
Likes:
1
Library:
1
The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics , allowing the FTC to consider whether the agency should settle the case, a filing late on Friday showed.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value